| Name | DS45500853 |
|---|
| Description | DS45500853 is an estrogen-related receptor α (ERRα) agonist. DS45500853 inhibits the binding between receptor-interacting protein 140 (RIP140) corepressor peptide (10 nM) and GST-ERRα ligand-binding domain (LBD; 1.2 μM) with an >IC50 value of 0.80 μM. DS45500853 can be used for the research of metabolic disorders, including type 2 diabetes mellitus (T2DM)[1]. |
|---|---|
| Related Catalog | |
| Target |
ERRα |
| References |
| Molecular Formula | C18H20O3 |
|---|---|
| Molecular Weight | 284.35 |